285
Participants
Start Date
November 4, 2004
Primary Completion Date
April 12, 2007
Study Completion Date
April 12, 2007
Salmeterol/fluticasone
Salmeterol/ fluticasone are a type of long acting beta-agonist (LABA). Salmeterol 50 microgram/ fluticasone 100 microgram combination will be administered to eligible subjects via inhalation route.
Fluticasone propionate
Fluticasone propionate is a type of LABA. Fluticasone 100 microgram dose will be administered to eligible subjects via inhalation route.
Salbutamol
Salbutamol metered dose inhaler will be provided to all subjects as a rescue medication.
GSK Investigational Site, Friedrichsfelde
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Frankfurt (Oder)
GSK Investigational Site, Schwedt
GSK Investigational Site, Lüneburg
GSK Investigational Site, Geesthacht
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Flensburg
GSK Investigational Site, Harrislee
GSK Investigational Site, Hanover
GSK Investigational Site, Minden
GSK Investigational Site, Detmold
GSK Investigational Site, Gütersloh
GSK Investigational Site, Bielefeld
GSK Investigational Site, Halle
GSK Investigational Site, Kassel
GSK Investigational Site, Wetzlar
GSK Investigational Site, Braunfels
GSK Investigational Site, Düsseldorf
GSK Investigational Site, Düsseldorf
GSK Investigational Site, Neuss
GSK Investigational Site, Neuss
GSK Investigational Site, Remscheid
GSK Investigational Site, Dortmund
GSK Investigational Site, Bochum
GSK Investigational Site, Bochum
GSK Investigational Site, Bochum
GSK Investigational Site, Bochum
GSK Investigational Site, Essen
GSK Investigational Site, Oberhausen
GSK Investigational Site, Bottrop
GSK Investigational Site, Wesel
GSK Investigational Site, Duisburg
GSK Investigational Site, Krefeld
GSK Investigational Site, Kleve-Materborn
GSK Investigational Site, Willich
GSK Investigational Site, Kempen
GSK Investigational Site, Osnabrück
GSK Investigational Site, Belm
GSK Investigational Site, Aachen
GSK Investigational Site, Euskirchen
GSK Investigational Site, Trier
GSK Investigational Site, Mainz
GSK Investigational Site, Mainz
GSK Investigational Site, Koblenz
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Wiesbaden
GSK Investigational Site, Niedernhausen
GSK Investigational Site, Mannheim
GSK Investigational Site, Schwetzingen
GSK Investigational Site, Heidelberg
GSK Investigational Site, Stuttgart
GSK Investigational Site, Stuttgart
GSK Investigational Site, Welzheim
GSK Investigational Site, Bönnigheim
GSK Investigational Site, Schwäbisch Hall
GSK Investigational Site, Sinsheim
GSK Investigational Site, Kehl
GSK Investigational Site, Ettenheim
GSK Investigational Site, Villingen-Schwenningen
GSK Investigational Site, Konstanz
GSK Investigational Site, Tuttlingen
GSK Investigational Site, Bad Krozingen
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Olching
GSK Investigational Site, Rosenheim
GSK Investigational Site, Freising
GSK Investigational Site, Bobingen
GSK Investigational Site, Nördlingen
GSK Investigational Site, Kaufbeuren
GSK Investigational Site, Pfullendorf
GSK Investigational Site, Nuremberg
GSK Investigational Site, Nuremberg
GSK Investigational Site, Lauf
GSK Investigational Site, Pegnitz
GSK Investigational Site, Forchheim
GSK Investigational Site, Tauberbischofsheim
GSK Investigational Site, Neuhaus am Rennweg
GSK Investigational Site, Cossebaude
GSK Investigational Site, Döbeln
GSK Investigational Site, Dresden
GSK Investigational Site, Dresden
GSK Investigational Site, Leipzig
GSK Investigational Site, Leipzig
GSK Investigational Site, Wurzen
Lead Sponsor
GlaxoSmithKline
INDUSTRY